US release of medtech/pharma payments to doctors criticized
This article was originally published in SRA
Executive Summary
There have been complaints aimed at the US Centers for Medicare & Medicaid Services' launch of its so-called "Open Payments" system, an online database of drug and medical device manufacturers' financial interactions with physicians, which is required under the Physician Payment Sunshine Act1,2.